Tehran University of Medical Sciences

Science Communicator Platform

Share By
Mesenchymal Stem Cell Therapies for Covid-19: Current Status and Mechanism of Action Publisher Pubmed



Sadeghi S1 ; Soudi S2 ; Shafiee A3 ; Hashemi SM1, 4, 5
Authors

Source: Life Sciences Published:2020


Abstract

The outbreak of COVID-19 in December 2019, has become an urgent and serious public health emergency. At present, there is no effective treatment or vaccine for COVID-19. Therefore, there is a crucial unmet need to develop a safe and effective treatment for COVID-19 patients. Mesenchymal stem cells (MSCs) are widely used in basic science and in a variety of clinical trials. MSCs are able to engraft to the damaged tissues after transplantation and promote tissue regeneration, besides MSCs able to secrete immunomodulatory factors that suppress the cytokine storms. Moreover, the contribution of MSCs to prevent cell death and inhibit tissue fibrosis is well established. In the current review article, the potential mechanisms by which MSCs contribute to the treatment of COVID-19 patients are highlighted. Also, current trials that evaluated the potential of MSC-based treatments for COVID-19 are briefly reviewed. © 2020 Elsevier Inc.
Related Docs
View other Related Docs
1. Therapeutic Potentials and Candidates for Covid-19, Iranian Journal of Science (2023)
2. Towards Treatment Planning of Covid-19: Rationale and Hypothesis for the Use of Multiple Immunosuppressive Agents: Anti-Antibodies, Immunoglobulins, and Corticosteroids, International Immunopharmacology (2020)
3. Allogenic Mesenchymal Stromal Cells and Their Extracellular Vesicles in Covid-19 Induced Ards: A Randomized Controlled Trial, Stem Cell Research and Therapy (2023)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (4)
Roodabeh Bahramsoltani (1)
Other Related Docs
4. Challenges Posed by Covid-19 in Cancer Patients: A Narrative Review, Cancer Medicine (2022)
5. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
6. Remdesivir: A Beacon of Hope From Ebola Virus Disease to Covid-19, Reviews in Medical Virology (2020)
7. Traditional Persian Medicine As a Holistic Therapeutic Approach for Managing Covid-19, Traditional Medicines and Natural Products as Preventive and Therapeutic Agents against COVID-19: a Promising Response to the Global Unprecedented Pandemic (2024)
8. Current Evidence on the Use of Anakinra in Covid-19, International Immunopharmacology (2022)
9. Safety and Efficacy of Imatinib, Nilotinib, and Artesunate in Covid-19 Patients: A Systematic Review of Current Evidence, Anti-Infective Agents (2024)
10. Crispr/Cas13: A Potential Therapeutic Option of Covid-19, Biomedicine and Pharmacotherapy (2020)
11. A One Year Follow of Patients With Multiple Sclerosis During Covid-19 Pandemic: A Cross-Sectional Study in Qom Province, Iran, Multiple Sclerosis and Related Disorders (2022)
12. Potential Therapeutic Applications of Extracellular Vesicles in the Immunopathogenesis of Covid-19, Pathology Research and Practice (2023)
13. Monoclonal Antibody As a Potential Anti-Covid-19, Biomedicine and Pharmacotherapy (2020)
14. An Overview on the Treatments and Prevention Against Covid-19, Virology Journal (2023)
15. Covid-19 and Disease-Modifying Therapies in Patients With Demyelinating Diseases of the Central Nervous System: A Systematic Review, Multiple Sclerosis and Related Disorders (2021)
16. Artesunate, Imatinib, and Infliximab in Covid-19: A Rapid Review and Meta-Analysis of Current Evidence, Immunity# Inflammation and Disease (2022)
17. Statins: Beneficial Effects in Treatment of Covid-19, Advances in Experimental Medicine and Biology (2023)
18. Host Factors: Implications in Immunopathogenesis of Covid-19, Pathology Research and Practice (2021)
19. Pharmacotherapeutic Considerations in Solid Organ Transplant Patients With Covid-19, Expert Opinion on Pharmacotherapy (2020)
20. Comparison of the Eight Different Treatment Regimens for the Hospitalized Patients With Covid-19: A Retrospective Cohort Study, Journal of Cellular and Molecular Anesthesia (2021)